Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus

Circulation

Volumn 101, Issue 15, 2000, Pages 1773-1779

  Evans, Marc ^a   Anderson, Richard A ^a   Graham, John ^c   Ellis, Gethin R ^a   Morris, Keith ^b   Davies, Stephen ^a   Jackson, Simon K ^a   Lewis, Malcolm J ^a   Frenneaux, Michael P ^a   Rees, Alan ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Diabetes mellitus; Endothelium; Lipemia; Stress

Indexed keywords

CIPROFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 17944401657     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.15.1773     Document Type: Article

References (44)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow up study. Diabetes. 1974;23:105-111.
2. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
3. Reaven GM, Chen YD. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev. 1988;4:639-652.
4. Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care. 1996;4:387-389.
5. Deman FHA, Castro Cabezas M, Van Barlingen HHJ, Erkelens DW, De Bruin TWA. Triglyceride rich lipoproteins in non-insulin dependent diabetes mellitus: postprandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest. 1996;26:89-108.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
7. West KM, Ahuja MM, Bennett PH. The role of circulating glucose and triglyceride concentrations and their interactions with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care. 1983;6:361-369.
8. Fontbonne A, Eschwege E, Richard J-L, Ducimetere P, Thibult N, Warnet J-M, Claude J-R, Rosselin GE. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia. 1989;32:300-304.
9. Lewis TV, Dart AM, Chin-Dusting JPF. Endothelium dependent relaxation by acetylcholine is impaired in humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol. 1999;33:805-811.
10. Lewis GF, O'Mera P, Soltys JD, Blackman P, Iverius H, Pugh WL, Getz GS, Polonsky KS. Fasting hypertriglyceridemia in non-insulin dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab. 1991;72:934-944.
11. Karpe F, Steiner G, Uffelman K, Olivecronna T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994;106:83-97.
12. Karpe F, Bard JM, Steiner G, Carlson LA, Fruchart JC, Hamsten A. HDL and alimentary lipemia: studies in men with myocardial infarction at young age. Arterioscler Thromb. 1993;13:11-22.
13. Plotnick GD, Correti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium dependent brachial artery vaso-activity following a single high fat meal. JAMA. 1997;278:1682-1686.
14. Goodfellow J, Ramsey MW, Luddington LA, Jones CH, Coates PA, Dunstan F, Lewis M, Owens DR, Henderson AH. Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ. 1996;312:744-745.
15. Steals B, Dallongeville J, Aureux J, Schoonjans K, Leitersdorf E, Fruchart J-C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98:2088-2093,
16. Weintraub MS, Charach G, Grosskopf I. Effect of bezafibrate and metformin on postprandial lipemia. Atherosclerosis. 1998;138(suppl I):s71-s75.
17. Patsch JR, Miesenbock G, Hopferweiser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Arterioscler Thromb. 1992;12:1336-1345.
18. Ramsey M, Goodfellow J, Jones C, Luddington L, Lewis M, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995;92:3212-3219.
19. Allain CC, Poon LS, Chan CSG, Richmond W. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
20. Whafield AW. Triglycerides: Determination After Enzymatic Hydrolysis: Methods of Enzymatic Analysis. New York, NY: Verlag Chemie Weinheim/Academic Press Inc; 1974;18331-18335.
21. Warnick GR, Nguyen T, Albers AA. Comparison of improved precipitation methods for quantification of HDL cholesterol. Clin Chem. 1995; 31:217-222.
22. Graham JM, Higgins JA, Gillott T, Taylor T, Wilkinson J, Ford T, Billington D. A novel method for the rapid separation of lipoproteins using self generating gradients of iodixanol. Atherosclerosis. 1996;124: 124-135.
23. John WG, Gray MR, Bates DL, Beacham JL. Enzyme immunoassay: a new technique for estimating hemoglobin A1C. Clin Chem. 1993;39: 663-666.
24. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap PBN. J Clin Invest. 1988;82:476-485.
25. Ashton T, Rowlands CC, Jones E, Young IS, Jackson SK, Davies B, Peters JR. Electron spin resonance spectroscopic detection of oxygen centred radicals in human serum following exhaustive exercise. Eur J Appl Physiol. 1998;77:498-502.
26. Evans JC, Jackson SK. ESR methods: an ESR and ENDOR study of biological systems using the technique of spin trapping and spin labeling. Anal Proc. 1990;27:215-217.
27. Mergener GW, Weglicki WB, Kramer JH. Postischemic free radical production in the venous blood of the regionally ischemic swine heart. Circulation. 1991;84:2079-2090.
28. Lundman P, Eriksson M, Schenck-Gustaffson K, Karpe F, Tornvall P. Transient triglyceridemia decreases vascular reactivity in young healthy men without risk factors for coronary heart disease. Circulation. 1997; 10:3266-3268.
29. Sattar N, Petrie JR, Jaap AJ. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis. 1998;138:229-235.
30. O'Brien SFO, Watts GF, Playford DA, Burke V, O' Neal DN, Best JD. Low density lipoprotein size, high density lipoprotein concentration and endothelial dysfunction in non-insulin dependent diabetes. Diabet Med. 1997;14:974-978.
31. Grenholdt MLN, Nordestgard BG, Wiebee BM, Wilhjelm JE, Sillesen H. Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques is associated with increased levels of triglyceride rich lipoproteins as well as increased plaque content. Circulation. 1998;97: 34-40.
32. Gianturco SH, Bradley WA, Gotto AM. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest. 1982;70:168-178.
33. Chung BH, Segrest JP. Cytotoxicity of remnants of triglyceride rich lipoproteins: an atherogenic insult? Adv Exp Med Biol. 1991;285: 341-351.
34. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kottie L, Kunitake ST, Havel RJ, Kane JP. Triglyceride rich lipoproteins isolated by selected affinity anti apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 1994;14:1767-1774.
35. Arbogast BW. Purification and identification of very low density lipoprotein toxicity preventing activity. Atherosclerosis. 1988;73: 259-267.
36. Demant T, Packard CJ, Stewart JP. Metabolism of triglyceride rich lipoproteins determines the occurrence of an atherogenic LDL phenotype. Atherosclerosis. 1997;134:344.
37. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis. 1998;141:1-15.
38. Watts GF, Playford DA. Dyslipoproteinemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: a hypothesis. Atherosclerosis. 1998;141:17-30.
39. Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockroft JR, Brett SE. Ritter JM. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am Coll Cardiol. 1997;29:964-968.
40. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9.
41. Wiztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
42. Tesfamarian B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263:583-592.
43. O'Donnel VB, Chumley PH, Hogg N, Bloodsworth A, Darley-Usmar VM, Freeman BA. Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry. 1997;36:15216-15223.
44. Petrie JR, Schinichiro U, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for the pathogenesis of cardiovascular disease. Circulation. 1996;93:1331-1333.